← Leaderboards
Walter J Koch
Duke University
$36,219,689
Attributed
$37,642,268
Total exposure
26
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$72,176,049 · 28
By mechanism
P01$51,912,929 · 18
R01$16,290,215 · 7
R37$3,947,905 · 1
R13$25,000 · 2
Top collaborators
- Jonathan S. Stamler4 shared
Most similar at Duke University
Same institution · by research overlap
- Marc G. Caron$32,189,154
- Robert J Lefkowitz$17,365,480
- Laura M Bohn$20,645,026
- William C Wetsel$2,175,976
- Neil J. Freedman$13,528,793
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureMyocardiumCardiacHeartLeadIn VivoSignal TransductionMuscle CellsMediatingMyocardialG Protein Coupled Receptor KinasePlayMouse ModelDesensitizationPhosphotransferasesMolecularRegulationStressInjuryCardiac MyocytesFunctional DisorderAnimal ModelG-Protein-Coupled ReceptorsPathogenesis
Grant awards (132)
Project 2$515,125
P01 · FY2025 · HL · contact PI
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$1,791,623
P01 · FY2024 · HL · contact PI
Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and Repair$724,176
R01 · FY2024 · HL · contact PI
Project 2$515,125
P01 · FY2024 · HL · contact PI
Administrative Core$255,947
P01 · FY2024 · HL · contact PI
Project 1: Targeting GRK5 in Cardiac Injury and Repair$255,946
P01 · FY2024 · HL · contact PI
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2023 · HL · contact PI
Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and Repair$702,607
R01 · FY2023 · HL · contact PI
Project 1: Targeting GRK5 in Cardiac Injury and Repair$435,875
P01 · FY2023 · HL · contact PI
Administrative Core$63,402
P01 · FY2023 · HL · contact PI
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2022 · HL · contact PI
Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and Repair$702,607
R01 · FY2022 · HL · contact PI
Project 1: Targeting GRK5 in Cardiac Injury and Repair$435,875
P01 · FY2022 · HL · contact PI
Targeting GRK2 in the Heart$338,246
R01 · FY2022 · HL · contact PI
Administrative Core$63,402
P01 · FY2022 · HL · contact PI
Targeting GRK2 in the Heart$58,003
R01 · FY2022 · HL · contact PI
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2021 · HL · contact PI
Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and Repair$715,769
R01 · FY2021 · HL · contact PI
Project 1: Targeting GRK5 in Cardiac Injury and Repair$435,875
P01 · FY2021 · HL · contact PI
Targeting GRK2 in the Heart$396,250
R01 · FY2021 · HL · contact PI
Administrative Core$63,402
P01 · FY2021 · HL · contact PI
Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies$2,401,275
P01 · FY2020 · HL · contact PI
Adrenergic and GRK regulation of exosomes for cardiac regeneration$453,944
P01 · FY2020 · HL · contact PI
Project 1: Targeting GRK5 in Cardiac Injury and Repair$435,875
P01 · FY2020 · HL · contact PI
Targeting GRK2 in the Heart$396,250
R01 · FY2020 · HL · contact PI
Administrative Core$63,401
P01 · FY2020 · HL · contact PI
Adrenergic and GRK regulation of exosomes for cardiac regeneration$461,341
P01 · FY2019 · HL · contact PI
Targeting GRK2 in the Heart$396,250
R01 · FY2019 · HL · contact PI
Dissecting GRK Function in the Heart$326,054
P01 · FY2019 · HL · contact PI
Novel Mechanisms of Cardiac Injury and Repair$2,316,690
P01 · FY2018 · HL · contact PI
Adrenergic and GRK regulation of exosomes for cardiac regeneration$468,524
P01 · FY2018 · HL · contact PI
Novel Roles for GRK5 in Myocardial Pathology$447,722
P01 · FY2018 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$387,500
R37 · FY2018 · HL · contact PI
Dissecting GRK Function in the Heart$326,054
P01 · FY2018 · HL · contact PI
Administrative Core$109,418
P01 · FY2018 · HL · contact PI
Novel Mechanisms of Cardiac Injury and Repair$2,316,690
P01 · FY2017 · HL · contact PI
Adrenergic and GRK regulation of exosomes for cardiac regeneration$475,500
P01 · FY2017 · HL · contact PI
Novel Roles for GRK5 in Myocardial Pathology$447,720
P01 · FY2017 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$387,500
R37 · FY2017 · HL · contact PI
Dissecting GRK Function in the Heart$326,054
P01 · FY2017 · HL · contact PI
Administrative Core$109,418
P01 · FY2017 · HL · contact PI
Novel Mechanisms of Cardiac Injury and Repair$2,316,690
P01 · FY2016 · HL · contact PI
Novel Roles for GRK5 in Myocardial Pathology$447,720
P01 · FY2016 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$387,500
R37 · FY2016 · HL · contact PI
Exploring GRK2 Inhibition in Repair of Post-MI Cardiac Failure$374,890
P01 · FY2016 · HL · contact PI
Dissecting GRK Function in the Heart$326,054
P01 · FY2016 · HL · contact PI
Administrative Core$109,418
P01 · FY2016 · HL · contact PI
Novel Mechanisms of Cardiac Injury and Repair$2,281,940
P01 · FY2015 · HL · contact PI
Novel Roles for GRK5 in Myocardial Pathology$442,755
P01 · FY2015 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$381,687
R37 · FY2015 · HL · contact PI
Exploring GRK2 Inhibition in Repair of Post-MI Cardiac Failure$369,267
P01 · FY2015 · HL · contact PI
Dissecting GRK Function in the Heart$340,804
P01 · FY2015 · HL · contact PI
GRK and b-Arrestin Signaling in Cardiac Regeneration$301,410
R01 · FY2015 · HL · contact PI
Administrative Core$104,454
P01 · FY2015 · HL · contact PI
Novel Mechanisms of Cardiac Injury and Repair$2,312,979
P01 · FY2014 · HL · contact PI
Novel Roles for GRK5 in Myocardial Pathology$447,003
P01 · FY2014 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$387,500
R37 · FY2014 · HL · contact PI
Exploring GRK2 Inhibition in Repair of Post-MI Cardiac Failure$367,392
P01 · FY2014 · HL · contact PI
Dissecting GRK Function in the Heart$343,197
P01 · FY2014 · HL · contact PI
GRK and b-Arrestin Signaling in Cardiac Regeneration$299,880
R01 · FY2014 · HL · contact PI
Administrative Core$109,243
P01 · FY2014 · HL · contact PI
Annual 2014 Symposium of the AHA Basic Cardiovascular Sciences Council$15,000
R13 · FY2014 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$425,382
R37 · FY2013 · HL · contact PI
Exploring GRK2 Inhibition in Repair of Post-MI Cardiac Failure$356,897
P01 · FY2013 · HL · contact PI
Dissecting GRK Function in the Heart$333,391
P01 · FY2013 · HL · contact PI
GRK and b-Arrestin Signaling in Cardiac Regeneration$291,312
R01 · FY2013 · HL · contact PI
Novel Mechanisms for Cardiac Injury and Repair$2,273,667
P01 · FY2012 · HL · contact PI
Novel Nuclear GRK5 Activity in the heart: Good or Bad?$390,152
P01 · FY2012 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$378,675
R37 · FY2012 · HL · contact PI
Exploring GRK2 Inhibition in Repair of Post-MI Cardiac Failure$374,630
P01 · FY2012 · HL · contact PI
Dissecting GRK Function in the Heart$350,200
P01 · FY2012 · HL · contact PI
GRK and b-Arrestin Signaling in Cardiac Regeneration$306,000
R01 · FY2012 · HL · contact PI
ADMINISTRATIVE CORE$76,498
P01 · FY2012 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$53,411
R37 · FY2012 · HL · contact PI
Annual Symposium of the AHA Basic Cardiovascular Sciences Council$10,000
R13 · FY2012 · HL · contact PI
"Novel Mechanisms for Cardiac Injury and Repair"$2,313,361
P01 · FY2011 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$386,250
R37 · FY2011 · HL · contact PI
S100A1: A Novel Modulator of Myocardial Infarct Inflammation and Regeneration$386,250
R01 · FY2011 · HL · contact PI
Dissecting GRK Function in the Heart$350,201
P01 · FY2011 · HL · contact PI
GRK and b-Arrestin Signaling in Cardiac Regeneration$310,000
R01 · FY2011 · HL · contact PI
Novel Nuclear GRK5 Activity in the heart: Good or Bad?$289,178
P01 · FY2011 · HL · contact PI
ADMINISTRATIVE CORE$289,169
P01 · FY2011 · HL · contact PI
"Novel Mechanisms for Cardiac Injury and Repair"$2,329,752
P01 · FY2010 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$386,250
R37 · FY2010 · HL · contact PI
S100A1: A Novel Modulator of Myocardial Infarct Inflammation and Regeneration$386,250
R01 · FY2010 · HL · contact PI
Adrenal GRKs and Adrenergic Signaling in Heart Failure$379,750
R01 · FY2010 · HL · contact PI
Novel Nuclear GRK5 Activity in the heart: Good or Bad?$364,976
P01 · FY2010 · HL · contact PI
Dissecting GRK Function in the Heart$364,201
P01 · FY2010 · HL · contact PI
ADMINISTRATIVE CORE$110,306
P01 · FY2010 · HL · contact PI
"Novel Mechanisms for Cardiac Injury and Repair"$2,329,949
P01 · FY2009 · HL · contact PI
Targeting GRK2 (BARK1) in Heart Failure$386,250
R37 · FY2009 · HL · contact PI
Adrenal GRKs and Adrenergic Signaling in Heart Failure$379,750
R01 · FY2009 · HL · contact PI
"Novel Mechanisms for Cardiac Injury and Repair"$2,345,340
P01 · FY2008 · HL · contact PI
Dissecting GRK Function in the Heart$415,208
P01 · FY2008 · HL · contact PI
Adrenal GRKs and Adrenergic Signaling in Heart Failure$379,750
R01 · FY2008 · HL · contact PI
Novel Nuclear GRK5 Activity in the heart: Good or Bad?$342,278
P01 · FY2008 · HL · contact PI
Targeting betaARK1 in Heart Failure$332,812
R01 · FY2008 · HL · contact PI
Gene Transfer and Myocardial Function$295,832
R01 · FY2008 · HL · contact PI
Administrative Core$109,783
P01 · FY2008 · HL · contact PI
Dissecting GRK Function in the Heart$411,787
P01 · FY2007 · HL · contact PI
Adrenal GRKs and Adrenergic Signaling in Heart Failure$387,500
R01 · FY2007 · HL · contact PI
Targeting betaARK1 in Heart Failure$332,812
R01 · FY2007 · HL · contact PI
Gene Transfer and Myocardial Function$295,832
R01 · FY2007 · HL · contact PI
Dissecting GRK Function in the Heart$397,452
P01 · FY2006 · HL · contact PI
Targeting betaARK1 in Heart Failure$342,752
R01 · FY2006 · HL · contact PI
Gene Transfer and Myocardial Function$304,668
R01 · FY2006 · HL · contact PI
Dissecting GRK Function in the Heart$395,583
P01 · FY2005 · HL
Gene Transfer and Myocardial Function$362,000
R01 · FY2005 · HL
Targeting betaARK1 in Heart Failure$351,000
R01 · FY2005 · HL
Dissecting GRK Function in the Heart$384,062
P01 · FY2004 · HL
Targeting betaARK1 in Heart Failure$351,000
R01 · FY2004 · HL
BETA-ADRENERGIC GENE TRANSFER AND MYOCARDIAL FUNCTION$274,750
R01 · FY2004 · HL
GENE TRANSFER TO ALTER TRANSPLANTED HEART FUNCTION$274,750
R01 · FY2004 · HL
TARGETING G PROTEINS IN VASCULAR INTIMAL HYPERPLASIA$307,265
R01 · FY2003 · HL
BETA-ADRENERGIC GENE TRANSFER AND MYOCARDIAL FUNCTION$147,908
R01 · FY2003 · HL
GENE TRANSFER TO ALTER TRANSPLANTED HEART FUNCTION$137,234
R01 · FY2003 · HL
GENE TRANSFER TO ALTER TRANSPLANTED HEART FUNCTION$134,246
R01 · FY2003 · HL
BETA-ADRENERGIC GENE TRANSFER AND MYOCARDIAL FUNCTION$121,592
R01 · FY2003 · HL
TARGETING G PROTEINS IN VASCULAR INTIMAL HYPERPLASIA$39,235
R01 · FY2003 · HL
TARGETING G PROTEINS IN VASCULAR INTIMAL HYPERPLASIA$346,500
R01 · FY2002 · HL
GENE TRANSFER TO ALTER TRANSPLANTED HEART FUNCTION$344,500
R01 · FY2002 · HL
TARGETING BETAARK1 IN HEART FAILURE$287,917
R01 · FY2002 · HL
BETA-ADRENERGIC GENE TRANSFER AND MYOCARDIAL FUNCTION$269,500
R01 · FY2002 · HL
TARGETING BETAARK1 IN HEART FAILURE$20,083
R01 · FY2002 · HL
TARGETING G PROTEINS IN VASCULAR INTIMAL HYPERPLASIA$346,500
R01 · FY2001 · HL
BETA-ADRENERGIC GENE TRANSFER AND MYOCARDIAL FUNCTION$319,500
R01 · FY2001 · HL
TARGETING BETAARK1 IN HEART FAILURE$308,000
R01 · FY2001 · HL
GENE TRANSFER TO ALTER TRANSPLANTED HEART FUNCTION$269,500
R01 · FY2001 · HL
TARGETING G PROTEINS IN VASCULAR INTIMAL HYPERPLASIA$346,500
R01 · FY2000 · HL
TARGETING BETAARK1 IN HEART FAILURE$308,000
R01 · FY2000 · HL
BETA ADRENERGIC GENE TRANSFER AND MYOCARDIAL FUNCTION$255,246
R01 · FY2000 · HL
GENE TRANSFER TO ALTER TRANSPLANTED HEART FUNCTION$224,771
R01 · FY2000 · HL